Hims & Hers Health Inc’s recent filing unveils that its Officer Melissa Baird acquired Company’s shares for reported $1.59 million on Jul 21 ’25. In the deal valued at $47.60 per share,33,333 shares were bought.
Then, Dudum Andrew bought 125,335 shares, generating $6,208,636 in total proceeds.
Before that, Dudum Andrew sold 47,534 shares. Hims & Hers Health Inc shares valued at $2,388,817 were divested by the Chief Executive Officer at a price of $50.25 per share. As a result of the transaction, Dudum Andrew now holds 190,126 shares, worth roughly $9.05 million.
Needham downgraded its Hims & Hers Health Inc [HIMS] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in early June has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering HIMS and has decreased its forecast on April 29, 2025 with a “Hold” recommendation from previously “Buy” rating. Morgan Stanley revised its rating on February 18, 2025. It rated HIMS as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock fall -5.52% to $47.6. Over the last five days, the stock has lost -8.51%. Hims & Hers Health Inc shares have risen nearly 116.46% since the year began. Nevertheless, the stocks have risen 96.86% over the past one year.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2025-06-13, dropping by -0.65 million shares to a total of 61.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 62.34 million shares. There was a decline of -1.05%, which implies that there is a negative sentiment for the stock.
